← All trials
NCT03405194
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2018
- Primary completion
- Aug 31, 2019
- Completion date
- Aug 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 256
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Haitian Group for the Study of Kaposi's Sarcoma and OpportunisticLead sponsor
- Cornell UniversityCollaborator
- Harvard UniversityOverall official - principal investigator
- Harvard UniversityCollaborator
- Gilead SciencesCollaborator
- Analysis Group, Inc.Collaborator
- Haitian Group for the Study of Kaposi's Sarcoma and OpportunisticOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.